Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Topical Application of Cocaine HCl 4% Solution on Safety/Efficacy & Cocaine HCl 4% & 10% Solution on Safety in Local Anesthesia for Diagnostic Procedures & Surgeries on or Through Accessible Mucous Membranes of the Nasal Cavities

NCT02500836 is registered in ClinicalTrials.gov with Lannett Company, Inc. as lead sponsor.

NCT NCT02500836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02500836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Topical Application of Cocaine HCl 4% Solution on Safety/Efficacy & Cocaine HCl 4% & 10% Solution on Safety in Local Anesthesia for Diagnostic Procedures & Surgeries on or Through Accessible Mucous Membranes of the Nasal Cavities
Lead sponsor
Lannett Company, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2015
Completion date
July 31, 2016
Enrollment
646 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

any ear nose or throat conditions, with identified need for a diagnostic procedure or surgery on or through the mucous membranes of the nasal cavities